X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE ABBOTT INDIA SUVEN LIFE/
ABBOTT INDIA
 
P/E (TTM) x 16.5 37.9 43.5% View Chart
P/BV x 3.9 11.0 35.7% View Chart
Dividend Yield % 0.4 0.6 80.0%  

Financials

 SUVEN LIFE   ABBOTT INDIA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-17
ABBOTT INDIA
Mar-17
SUVEN LIFE/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs2295,190 4.4%   
Low Rs1514,351 3.5%   
Sales per share (Unadj.) Rs42.71,382.9 3.1%  
Earnings per share (Unadj.) Rs6.9130.2 5.3%  
Cash flow per share (Unadj.) Rs8.5137.9 6.2%  
Dividends per share (Unadj.) Rs1.0040.00 2.5%  
Dividend yield (eoy) %0.50.8 62.8%  
Book value per share (Unadj.) Rs52.4652.7 8.0%  
Shares outstanding (eoy) m127.2821.25 599.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.43.4 128.8%   
Avg P/E ratio x27.736.6 75.6%  
P/CF ratio (eoy) x22.234.6 64.3%  
Price / Book Value ratio x3.67.3 49.6%  
Dividend payout %14.630.7 47.5%   
Avg Mkt Cap Rs m24,158101,373 23.8%   
No. of employees `0001.03.1 33.0%   
Total wages/salary Rs m5223,453 15.1%   
Avg. sales/employee Rs Th5,349.79,531.9 56.1%   
Avg. wages/employee Rs Th513.51,119.9 45.9%   
Avg. net profit/employee Rs Th858.1897.3 95.6%   
INCOME DATA
Net Sales Rs m5,43529,387 18.5%  
Other income Rs m211576 36.6%   
Total revenues Rs m5,64629,963 18.8%   
Gross profit Rs m1,2913,973 32.5%  
Depreciation Rs m214164 130.3%   
Interest Rs m5720 278.4%   
Profit before tax Rs m1,2314,365 28.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3591,598 22.4%   
Profit after tax Rs m8722,767 31.5%  
Gross profit margin %23.713.5 175.6%  
Effective tax rate %29.236.6 79.6%   
Net profit margin %16.09.4 170.4%  
BALANCE SHEET DATA
Current assets Rs m4,91718,906 26.0%   
Current liabilities Rs m1,1866,297 18.8%   
Net working cap to sales %68.642.9 160.0%  
Current ratio x4.13.0 138.1%  
Inventory Days Days6262 99.9%  
Debtors Days Days3122 142.2%  
Net fixed assets Rs m3,1541,159 272.2%   
Share capital Rs m127213 59.9%   
"Free" reserves Rs m6,54313,657 47.9%   
Net worth Rs m6,67013,869 48.1%   
Long term debt Rs m2590-   
Total assets Rs m8,15720,638 39.5%  
Interest coverage x22.7215.0 10.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.71.4 46.8%   
Return on assets %11.413.5 84.3%  
Return on equity %13.119.9 65.5%  
Return on capital %18.631.6 58.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,9960-   
Fx outflow Rs m9590-   
Net fx Rs m4,0370-   
CASH FLOW
From Operations Rs m1,0883,072 35.4%  
From Investments Rs m-3,107-1,554 199.9%  
From Financial Activity Rs m-300-898 33.4%  
Net Cashflow Rs m-2,319621 -373.7%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 7.9 -  
FIIs % 0.0 0.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 17.1 213.5%  
Shareholders   37,287 18,270 204.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   ALEMBIC PHARMA  STRIDES SHASUN LTD  FDC LTD.  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare SUVEN LIFE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Green; Metal Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

ABBOTT INDIA surges by 5%; BSE HEALTHCARE Index Up 0.5%

Jun 20, 2018 | Updated on Jun 20, 2018

ABBOTT INDIA share price has surged by 5% and its Current Market Price is Rs 7,284. The BSE HEALTHCARE is up by 0.49%. The top gainers in the BSE HEALTHCARE Index is ABBOTT INDIA (up 5.08%). The top losers are WOCKHARDT LTD. (down 0.04%) and SYNGENE INTERNATIONAL (down 0.15%).

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Jun 20, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - AJANTA PHARMA COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS